SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

CANCER, E.  y  GRUPO DE TRABAJO OBESMINVA DE LA SENPE et al. Técnicas mínimamente invasivas emergentes en el tratamiento de la obesidad. Nutr. Hosp. [online]. 2012, vol.27, n.4, pp.1025-1030. ISSN 0212-1611.  http://dx.doi.org/10.3305/nh.2012.27.4.5867.

    1. Tsesmeli N, Coumaros D. Review of endoscopic devices for weight reduction: old and new balloons and implantable prostheses. Endoscopy 2009; 41 (12): 1082-9. [ Links ]

    2. Carvalho GL, Barros CB, Okazaki M, Novaes ML. An Improved Intragastric Balloon Procedure Using a New Balloon: Preliminary Analysis of Safety and Efficiency. Obes Surg 2009; 19: 237-24. [ Links ]

    3. Lopasso, F P. Sakai P, Gazi B, Artifon, E. A Pilot Study to Evaluate the Safety, Tolerance, and Efficacy of a Novel Stationary Antral Balloon (SAB) for Obesity. Journal of Clinical Gastroenterology 2008; (42) 1: 48-53. [ Links ]

    4. Gaggiotti G, Tack J, Garrido AB, Palau M, Cappelluti G, Di Matteo F. Adjustable totally implantable intragastric prosthesis (ATIIP). Endosgast for treatment of morbid obesity: one-year follow-up of a multicenter prospective clinical survey. Obes Surg 2007; 17: 949-56. [ Links ]

    5. Mahmood Z, McMahon BP, Arfin Q et al. Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow-up. Gut 2003; 52: 34-9. [ Links ]

    6. Schwartz MP, Wellink H, Gooszen HG et al. Endoscopic gastroplication for the treatment of gastro-oesophageal reflux disease: a randomised, sham-controlled trial. Gut 2007; 56: 20-8. [ Links ]

    7. Rothstein RI, Filipi CJ. Endoscopic suturing for gastroesophageal reflux disease: clinical outcome with the Bard EndoCinch. Gastrointest. Endosc Clin N Am 2003; 13: 89-101. [ Links ]

    8. Fogel R, De Fogel J, Bonilla Y et al. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc 2008; 68: 51-8. [ Links ]

    9. Brethauer SA, Chand B, Schauer PR et al. Transoral gastric volume reduction for weight management: technique and feasibility in 18 patients. Surg Obes Relat Dis 2010; 6: 689-94. [ Links ]

    10. Moreno C, Closset J, Dugardeyn S et al. Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy 2008; 40: 406-13. [ Links ]

    11. Thompson CC, Brethauer SA, Chand B et al. M1259 Transoral Gastric Volume Reduction as an Intervention for Weight Management (TRIM) Multicenter Feasibility Study: a report of early outcomes. Gastroenterology 2009; 136: A-384. [ Links ]

    12. Deviere J, Ojeda Valdes G et al. Safety, feasibility and weight loss after transoral gastroplasty: first human multicenter study. Surg Endosc 2008; 22: 589-98. [ Links ]

    13. Chiellini G, Iaconelli A, Familiari P et al. Study of the effects of transoral gastroplasty on insulin sensitivity and secretion in obese subjects. Nutr Metab Cardiovasc Dis 2010; 20: 202-7. [ Links ]

    14. De Jong K, Mathus-Vliegen EM, Velchuyzen EA et al. Short-term safety and efficacy of the trans-oral endoscopic restrictive implant system for the treatment of obesity. Gastrointest Endosc 2010; 71: 978-82. [ Links ]

    15. Cigaina V, Saggioro A, Rigo V, Pinato G, Ischai S. Long-term effects of gastric pacing to reduce feed intake in swine. Obes Surg 1996; 6: 250-253. [ Links ]

    16. Cigaina V, Pinato G, Rigo V et al. Gastric peristalsis control by mono situ electric stimulation: a preliminary study. Obes Surg 1996; 6: 247-249. [ Links ]

    17. Cigaina V, Rigo V, Greenstein RJ. Gastric myo-electrical pacing as therapy for morbid obesity: preliminary results. Obes Surg 1999; 9: 333-334. [ Links ]

    18. Cigaina V. Gastric pacing as therapy for morbid obesity: preliminary results. Obes Surg 2002; 12: 12S-16S. [ Links ]

    19. Shikora SA, Bessler M, Fisher BL, Trigilio C, Moncure M, Greenstein R. Laparoscopic insertion of the Implantable gastric stimulator (IGStm): initial surgical experience. Obes Surg 2000; 10: 315. [ Links ]

    20. De Luca M, Segato G, Busetto L, Favretti F et al. Progress in Implantable Gastric Stimulation: Summary of results of the European Multicenter study. Obes Surg 2004; 14: 33-39. [ Links ]

    21. Bohdalian A, Ludvik B, Guerci B, Bresler L et al. Improvement in glycemis control by gastric electrical stimulation (TANTALUS) in overweight subjects with type 2 diabetes. Surg Endosc 2009; 23: 1955-60. [ Links ]

    22. McLoughlin P. Transcend Implantable Gastric stimulator (IGS) for the treatment of morbid obesity. ANZHSN (Horizon Scanning Technology Prioritising Summary). July 2005. Updated June 2006. [ Links ]

    23. Hasler WL. Methods of gastric electrical stimulation and pacing: a review of their benefits and mechanisms of action in gastroparesis and obesity. Neurogastroenterol Motil 2009; 21:229-43. [ Links ]

    24. Gui D, De Gaetano A, Spada PL, Viggiano A, Cassetta E, Albanese A. Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats. Aliment Pharmacol Ther 2000; 14: 829-34. [ Links ]

    25. Albani G, Petroni ML, Mauro A, Liuzzi A, Lezzi G, Verti B. Safety and efficacy of therapy with botulinum toxin in obesity: a pilot study. J Gastroenterol 2005; 40: 833-5. [ Links ]

    26. Gui D, Mingrone G, Valenza V, Spada PL, Mutignani M, Runfola M. Effect of botulinum toxin antral injection on gastric emptying and weight reduction in obese patients: a pilot study. Aliment Pharmacol Ther 2006; 1 (23): 675-80. [ Links ]

    27. Mittermair R, Keller C, Geibel J. Intragastric injection of botulinum toxin A for the treatment of obesity. Obes Surg 2007; 17:732-6. [ Links ]

    28. García-Compean D, Mendoza-Fuerte E, Martínez JA, Villarreal I, Maldonado H. Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity. Results of a pilot study. Gastroenterol Clin Biol 2005; 29: 789-91. [ Links ]

    29. Júnior AC, Savassi-Rocha PR, Coelho LG, Spósito MM, Albuquerque W, Diniz MT. Botulinum A toxin injected into the gastric wall for the treatment of class III obesity: a pilot study. Obes Surg 2006; 16: 335-43. [ Links ]

    30. Foschi D, Corsi F, Lazzaroni M, Sangaletti O, Riva P, La Tartara G. Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study. Int J Obes 2007; 31: 707-12. [ Links ]

    31. Topazian M, Camilleri M, De La Mora-Levy J, Enders FB, Foxx-Orenstein AE, Levy MJ. Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study. Obes Surg 2008; 18: 401-7. [ Links ]

    32. Gersin KS, Keller JE, Stefanidis D, Simms CS, Abraham DD, Deal SE, Kuwada TS, Heniford BT. Duodenal-jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov 2007; 14: 275-8. [ Links ]

    32. Rodríguez-Grunert L, Galvao Neto MP, Alamo M, Ramos AC, Baez PB, Tarnoff M. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis 2008; 4: 55-9. [ Links ]

    33. Tarnoff M, Rodríguez L, Escalona A, Ramos A, Neto M, Alamo M, Reyes E, Pimentel F, Ibanez L. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc 2009; 23: 650-6. [ Links ]

    34. Gersin KS, Rothstein RI, Rosenthal RJ, Stefanidis D, Deal SE, Kuwada TS, Laycock W, Adrales G, Vassiliou M, Szomstein S, Heller S, Joyce AM, Heiss F, Nepomnayshy D. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc 2010; 71: 976-82. [ Links ]

    35. Escalona A, Yáñez R, Pimentel F, Galvao M, Ramos AC, Turiel D, Boza C, Awruch D, Gersin K, Ibáñez L. Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity. Surg Obes Relat Dis 2010; 6: 126-31. [ Links ]

    36. Dunkin B, Eubanks S, Marks J, Marohn M et al. SAGES position statement on endolumenal therapies for gastrointestinal diseases. Scope 2009; 9 (1): 14-16. [ Links ]

    37. Coté GA, Edmundowicz SA. Emerging technology: endoluminal treatment of obesity. Gastrointest Endosc 2009; 70: 991-9. [ Links ]

    38. Levitzki B, Wassef W. Endoscopic management in the bariatric surgical patient. Curr Opin Gastroenterol 2010; 26: 632-9. [ Links ]

    39. Kumar N, Thompson Ch. Endoscopic solutions for weight loss. Curr Opin Gastroenterol 2011; 27: 407-411. [ Links ]

    40. Muñoz M, Mazure RA, Culebras JM. Obesidad y sistema inmune. Nutr Hosp 2004; 19: 319-32. [ Links ]

    41. Rodríguez-Rodríguez E, López-Plaza B, López-Sobaler AMa, Ortega RMa. Prevalencia de sobrepeso y obesidad en adultos españoles. Nutr Hosp 2011; 26: 355-36. [ Links ]